InsidersTradesSigma
Follow the Sunshine Biopharma, Inc stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Sunshine Biopharma, Inc has recorded 5 insider filings. Market capitalisation: €2.8m. The latest transaction was filed on 5 March 2024 (Acquisition). Among the most active insiders: Slilaty Steve N.. All data is openly available.
5
Insider Decl.
n/a
Thresholds
€61,633
4 ops.
Buy Volume
€87,098
1 ops.
Sell Volume
45Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 March 2024
Declarations5 total
100,000 shares@ US$0.109.4% of flowSeries B Preferred StockSEC:0001683168-24-001322:0
Canonical exit: 2 Jun 2024 (T+90)
20,000 shares@ US$0.101.9% of flowSeries B Preferred StockSEC:0001683168-24-000879:0
Canonical exit: 8 May 2024 (T+90)
30,000 shares@ US$0.763543.9% of flowCommon StockSEC:0001683168-22-008144:0
Canonical exit: 28 Feb 2023 (T+90)
25,000 shares@ US$1.220.65% mcap100.0% of flowCommon StockSEC:0001683168-22-004178:0
Canonical exit: 1 Sept 2022 (T+90)
990,000 shares@ US$0.102.00% mcap100.0% of flowSeries B Preferred StockSEC:0001683168-22-001185:0
5 of 5 declarations
About Sunshine Biopharma, Inc
Sunshine Biopharma, Inc is a company focused on developing drugs for the treatment of cancer and other diseases. It is listed on NASDAQ under the symbol SBFM.